
Themis Medicare Limited has informed the Exchange regarding a press release dated January 03, 2023, titled " Themis Medicare Launches Lenzetto�� Global brand of Estradiol Novel Drug Delivery System for treatment of Menopausal symptoms .".
Filed with NSE ·

Themis Medicare Limited has informed the Exchange regarding a press release dated January 03, 2023, titled " Themis Medicare Launches Lenzetto�� Global brand of Estradiol Novel Drug Delivery System for treatment of Menopausal symptoms .".
6ix hasn’t read this filing yet.
Themis Medicare Limited on 6ix
Follow Themis Medicare into a list and get an email when it puts out news.
Follow Themis Medicare